Zvláštní léčebný program – tamoxifen

This document concerns a special treatment program focused on tamoxifen. It was published on August 4, 2026, by the Department of Drug Availability. The program includes a list of unregistered medicinal products. From these products, individually prepared medicinal products (IPLP) can be prepared. The list contains information such as the name of the unregistered drug, its strength, dosage form, package size, and number of blisters. Furthermore, batch numbers, expiration dates, number of packages, excipients, and distributor are listed. Also included is a link to patient information about tamoxifen in PDF format, with a size of 262 kB.